The readability, suitability, and content features of eczema action plans in the United States

Pediatric Dermatology, EarlyView.
Source: Pediatric Dermatology - Category: Dermatology Authors: Source Type: research

Related Links:

Publication date: Available online 14 September 2019Source: Actas Dermo-Sifiliográficas (English Edition)Author(s): A. López-Cabañas
Source: Actas Dermo-Sifiliograficas - Category: Dermatology Source Type: research
This article summarizes the most important treatment modalities based on case reports and series, clinical studies, guidelines and expert recommendations. PMID: 31515578 [PubMed - as supplied by publisher]
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - Category: Dermatology Tags: Hautarzt Source Type: research
Authors: Mahler V, Dickel H Abstract The head and hands are the two most common locations for allergic contact dermatitis manifestation. In hand eczema, contact with a contact allergen is a frequent (co-)factor in the triggering and maintenance of eczema. For all hand eczemas lasting longer than 3 months, an allergological examination by means of patch testing is recommended. In patients with allergic contact dermatitis of the hands, nickel, MCI/MI, fragrance mix I, cobalt, thiuram mix, Balsam of Peru, chromium and fragrance mix II have been described in a multicenter European study as...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - Category: Dermatology Tags: Hautarzt Source Type: research
CONCLUSION: The exact understanding of the individual pathogenesis in single hand eczema patients is essential in order to provide specific advice on allergen avoidance, skin protection and basic treatment and to initiate appropriate therapeutic measures. PMID: 31501971 [PubMed - as supplied by publisher]
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - Category: Dermatology Tags: Hautarzt Source Type: research
Condition:   Dermatitis, Atopic Intervention:   Drug: BI 655130 Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Atopic Dermatitis Eczema Interventions:   Device: Berry Oil Cream;   Other: Reference Cream Sponsors:   Petra Larmo;   Cliniscan Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Dermatitis, Atopic Intervention:   Drug: BI 655130 Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Atopic Dermatitis Eczema Interventions:   Device: Berry Oil Cream;   Other: Reference Cream Sponsors:   Petra Larmo;   Cliniscan Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Dermatitis, Atopic Intervention:   Drug: BI 655130 Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Atopic Dermatitis Eczema Interventions:   Device: Berry Oil Cream;   Other: Reference Cream Sponsors:   Petra Larmo;   Cliniscan Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dermatology | Eczema | Pediatrics | Skin | USA Health